. (2024). Treatment pathways, economic burden and clinical outcomes in new users of inhaled corticosteroid/long-acting B(2)-agonist dual therapy with chronic obstructive pulmonary disease in a primary care setting in England: a retrospective cohort study. Bmj Open, 14, e072361. http://doi.org/10.1136/bmjopen-2023-072361
UK data driving real-world evidence